Envision Healthcare anticipates pricing its upcoming IPO for between $20 and $23 per share. The company has applied to list its shares under the symbol EVH on the NYSE. Owned by Clayton, Dubilier & Rice, Envision provides physician-led, outsourced medical services in the U.S. The company markets its services to more than 20,000 affiliated clinicians under its EmCare and AMR brands. CD&R acquired the company in 2011 in a deal valued at $3.2 billion.